1461 / 1851
Combined modality therapy still represents a standard
for patients
affected with early stage HL. Chemotherapy alone can be considered in some
patients, after a discussion with a Radiation Oncologist to hear about
PROs/CONs in his/her particular case
Interim-PET studies confirmed that
even PET-negative patients are more
likely to fail without RT
and modification of the treatment schedule
according to PET-scan is experimental
Radiation oncologists should be aware of the opportunity to
minimize the risks
of late toxicity by using smaller fields and most recent
technological improvements in radiation planning and delivery.
A balanced multi-disciplinary evaluation
of individual patients should
be
encouraged
for the proper selection of
the best strategy
according to
age, disease extension, secondary cancer and heart diseases risk profile.
Take Home Message (Early Stage HL)